Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Whole Blood Hyperthermia and ICE Chemotherapy in Sarcoma
NCT00002974Phase 2Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Jul 1996
- Primary completion
- Jul 2001
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ifosfamide, carboplatin and etoposide in sarcoma, sponsored by University of Wisconsin–Madison. Primary endpoint: Efficacy of WBH and ICE combination. Started Jul 1996; status: completed.
02
Drugs
ifosfamidecarboplatinetoposide
03
Conditions
sarcoma
Beyond the preview
Go deeper on NCT00002974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002974.